OR WAIT null SECS
November 14, 2019
Norwegian clinical-stage immunoncology company, Lytix Biopharma, has entered into a clinical collaboration with US-based Iovance Biotherapeutics.
November 12, 2019
The plant in Singen, Germany will be used for formulation, filling, and packaging of Takeda’s vaccine candidate.
Developers of biosimilars have become dismayed with difficulties in gaining acceptance and reimbursement from the US healthcare system.
November 07, 2019
The new addition will also launch a single-use bioreactor for the 93,000-ft2 facility.
GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory platform to accelerate production of antibody drugs in the Guangzhou region.
November 06, 2019
Through the agreement, Samsung will provide flexible business terms while offering full regulatory support and improved batch release from small to large scale.
The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.
November 01, 2019
Intertek has announced that it has expanded its center of excellence for biopharmaceutical services in Manchester, United Kingdom, to support the development of biologics and gene therapies.
FDA has approved Vumerity (diroximel fumarate), a new oral drug for relapsing forms of multiple sclerosis.
Breaking with tradition, a compounding facility won for overall operational excellence, while biopharma facilities took home awards in various categories.